Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Phase Ib Study of Osimertinib Plus Ramucirumab in Japanese Lung Cancer Patients With EGFR Mutation

Phase Ib Study of Osimertinib Plus Ramucirumab in Japanese Lung Cancer Patients With EGFR Mutation http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Anticancer Research Unpaywall

Phase Ib Study of Osimertinib Plus Ramucirumab in Japanese Lung Cancer Patients With EGFR Mutation

Loading next page...
 
/lp/unpaywall/phase-ib-study-of-osimertinib-plus-ramucirumab-in-japanese-lung-cancer-OYcPm8obmw

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0250-7005
DOI
10.21873/anticanres.14844
Publisher site
See Article on Publisher Site

Abstract

Journal

Anticancer ResearchUnpaywall

Published: Jan 30, 2021

There are no references for this article.